SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021944
Filing Date
2020-11-18
Accepted
2020-11-18 16:20:38
Documents
48
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 939398
2 ex31-1.htm EX-31.1 18851
3 ex32-1.htm EX-32.1 8653
  Complete submission text file 0001493152-20-021944.txt   4101177

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atrx-20200930.xsd EX-101.SCH 30827
5 XBRL CALCULATION FILE atrx-20200930_cal.xml EX-101.CAL 37451
6 XBRL DEFINITION FILE atrx-20200930_def.xml EX-101.DEF 135983
7 XBRL LABEL FILE atrx-20200930_lab.xml EX-101.LAB 275093
8 XBRL PRESENTATION FILE atrx-20200930_pre.xml EX-101.PRE 207241
9 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 647981
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 201325348
SIC: 2834 Pharmaceutical Preparations